Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-27138 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- FCGR2B Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Recommended positive controls: THP-1.
- Concentration
- 1 mg/mL
Submitted references Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
Burgess M, Mapp S, Mazzieri R, Cheung C, Chambers L, Mattarollo SR, Mollee P, Gill D, Saunders NA
Oncogene 2017 Apr 27;36(17):2366-2376
Oncogene 2017 Apr 27;36(17):2366-2376
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot using FCGR2B Polyclonal Antibody (Product # PA5-27138). Sample (30 µg of whole cell lysate). Lane A: THP-1. 10% SDS PAGE. FCGR2B Polyclonal Antibody (Product # PA5-27138) diluted at 1:1,000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of CD32B/FCGR2B in methanol-fixed A431 cells using a CD32B/FCGR2B polyclonal antibody (Product # PA5-27138) at a 1:500 dilution.
